Biomarker reveals inflammatory changes in the brain with Alzheimer’s disease
Inflammatory responses in the brain have long been suspected of playing a role in Alzheimer’s disease, but are challenging to monitor in the living human brain. An international collaboration including researchers at MultiPark, Lund University has made it possible to detect elevated levels of Galectin-3, a protein expressed in the immune cells inside the brain. The results were published in Acta N
https://www.neuroinflammation.lu.se/article/biomarker-reveals-inflammatory-changes-brain-alzheimers-disease - 2025-11-05
